Modern trends in radiotherapy
Authors:
Pavel Šlampa
Authors‘ workplace:
Klinika radiační onkologie MOÚ a LF MU, Brno
Published in:
Čas. Lék. čes. 2020; 159: 261-267
Category:
Review Article
Overview
Radiotherapy is a dynamically developing field of cancer treatment. Advances in radiotherapy are significantly related to new knowledge in radiobiology, the introduction of new systems in radiodiagnostics and radiation therapy planning. The technical development of irradiation systems over the last 10 years has greatly improved the quality of radiation therapy. The constant aim of modern radiation therapy is to minimize the toxicity of radiotherapy while maintaining the therapeutic effect. With the development of radiotherapy, however, the issue of so-called financial toxicity of various radiation techniques and disproportionate increase in treatment spending, regardless of cost-effectiveness.
Keywords:
radiotherapy – Radiosurgery – brachytherapy – modern techniques
Sources
- Šlampa P a kol. Radiační onkologie. Maxdorf, Praha, 2020.
- Šlampa P. Žlutý kopec. Historie léčby zářením v Brně na Žlutém kopci. Maxdorf, Praha, 2018.
- Šlampa P, Petera J a kol. Radiační onkologie. Galén, Karolinum, Praha, 2007.
- Kahalley LS, Peterson R, Ris MD et al. Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020; 38: 454–461.
- Langendijk JA, Boersma JL, Rasch CRN et al. Clinical trial strategies to compare protons with photons. Semin Radiat Oncol 2018; 28: 79–87.
- Petera J. Kontroverze protonové terapie u nádorů centrální nervové soustavy. Klinická onkologie 2018; 31: 24–27.
- Burkoň P, Slávik M, Kazda T et al. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study. Neoplasma 2019; 66: 315–325.
- Yeung R, Hamm J, Liu M et al. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases. Radiat Oncol 2017; 12: 105.
- Schäfer R, Strnad V, Šlampa P et al.; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). Quality of life in patients treated with accelerated partial breast irradiation using multicatheter interstitial brachytherapy versus whole-breast irradiation: 5-year results from the randomized, phase 3, non-inferiority GEC-ESTRO trial. Lancet Oncol 2018; 19: 834–844.
- Hamming-Vrieze O, van Kranen SR, Heemsbergen WD et al. Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy. Radiother Oncol 2017; 122: 224–228.
- Havránková R (ed.). Klinická radiobiologie. Grada, Praha, 2020.
- Jefferson T, Formoso G, Venturelli F et al. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies. Recenti Prog Med 2019; 110: 566–586.
- Wang C et al. Artificial intelligence in radiotherapy treatment planning: present and future. Technol Cancer Res Treat 2019; 18: 1533033819873922.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Principles and new perspectives in the vaccination against SARS-CoV-2 virus
- Season of the year, vitamin D and COVID-19
- Age is not a disease: Evolution of protective antibodies against SARS-CoV-2 in seniors from the Břevnice nursing home
- Biological effects of ionizing radiation